Journals / MN Kardiyoloji / 2018 / Cilt: 25 - Sayı: 2

Acute Heart Failure

Akut Kalp Yetersizliği

Pages
100–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, diagnosis and treatment of acute heart failure is summarised according to latest guideline and literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute heart failure is a life threatening clinical situation which needs to be diagnosed and treated emergently.
📊
Key Findings & Data:Latest guideline of heart failure was published in 2016 by ESC and had summarised the clinical diagnosis and treatment mentality in details.
💡
Conclusion & Impact:Here, diagnosis and treatment of acute heart failure is summarised according to latest guideline and literature.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Acute heart failure is a life threatening clinical situation which needs to be diagnosed and treated emergently. Latest guideline of heart failure was published in 2016 by ESC and had summarised the clinical diagnosis and treatment mentality in details. Bedside physical ex- amination and clinical classification of the patient is important in directing the therapy and also gives prognostic information. First steps in suspicion of acute heart failure includes the emergent care at the first contact and the urgent care which includes the first 60-120 minutes of admission. After emergent care, diagnosis of possible triggering factors and their treatment is very important. Congestion and perfusion status of the patient determines the choice of pharmacological agents for treatment. Here, diagnosis and treatment of acute heart failure is summarised according to latest guideline and literature.

Özet

Akut kalp yetersizliği hayatı tehdit eden bir klinik olduğundan hızlı değerlendirme ve acil tedavi gerektirmektedir. Son yayınlanan ESC 2016 Kalp Yetersizliği Kılavuzu akut kalp yetersizliğinde klinik ve tedavi yaklaşımlarını güzel bir şekilde özetlemiştir. Yatak başında fizik muayene ile yapılacak klinik sınıflandırma ilk safhada tedaviyi yönlendirmede faydalı olacağı gibi prognostik bilgiler de vermektedir. Akut kalp yetersizliği şüphesi durumunda atılacak adımlar ilk temasta acil müdahale dönemi ve başvuru sonrasındaki ilk 60-120 daki- kayı kapsayan hızlı müdahale dönemi olarak ikiye ayrılmıştır. Acil müdahale sonrası indükleyici faktörlerin tespiti ve bunlara yönelik te- davi oldukça önemlidir. Fizik muayenedeki konjesyon ve perfüzyon durumu, hastada seçilecek farmakolojik tedavinin de seçimini belir- lemektedir. Son kılavuz ve güncel yayınlar eşliğinde akut kalp yetersizliği tanı ve tedavisi özetlenmiştir.

🔖

Cite This Article

ÖZYÜNCÜ, N. (2018). Acute Heart Failure. MN Kardiyoloji, Cilt: 25 - Sayı: 2, 100–107. https://ajindex.com/articles/297240

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ponikowski P, Voors AA, Anker SD, et al. Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treat- ment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016 Jul 14;37(27):2129-200.
  2. Farmakis D, Parissis J, Filippatos G. Acute heart failure: epi- demiology, classification and pathophysiology. The ESC textbook of intensive and acute cardiovascular care. Oxford University Press, 2 nd ed. 2015:459-469.
  3. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797-804. Stevenson LW. Design of therapy for advanced heart fail- ure.Eur J Heart Fail 2005;7(3):323-31. Killip T 3 rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 pa- tients. Am J Cardiol 1967;20(4):457-64.
  4. Maisel AS, Peacock WF, McMullin N, et al. Timing of im- munoreactive B-type natriuretic peptide levels and treat- ment delay in acute decompensated heart failure: an AD- HERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008;52(7): 534-40. Adalet K. Akut kalp yetersizliği ve akciğer odemi. Klinik kardiyoloji tanı ve tedavi. İstanbul Tıp kitabevi, 2013:657- 67 Kelder JC, Cowie MR, McDonagh TA, et al. Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis. Heart 2011;97(12):959-63.
  5. Gupta DK, Wang TJ. Natriuretic Peptides and Cardio me - tabolic Health. Circ J 2015;79(8):1647-55.
  6. Felker GM, Mentz RJ, Teerlink JR, et al. Serial high sensitiv- ity cardiac troponin T me a surement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail 2015;17(12):1262-70.
  7. Konstantinides SV, Torbicki A, Agnelli G, et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).2014 ESC guidelines on the diagnosis and manage- ment of acute pulmonary embolism. Eur Heart J 2014;35(43):3033-69.
  8. Roffi M, Patrono C, Collet JP, et al. Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC Guidelines for the management of acute coronary syndromes